Document Detail

Transurethral plasma vaporization of the prostate: 3-month functional outcome and complications.
MedLine Citation:
PMID:  21044248     Owner:  NLM     Status:  In-Process    
OBJECTIVE: To evaluate the early functional outcomes of transurethral plasma vaporization of the prostate (TUVis) in a multicentre study.
PATIENTS AND METHODS: A prospective multicentre observational study was conducted in eight urology departments. The inclusion criterion was benign prostatic hyperplasia (BPH) requiring surgical treatment. Patients on anti-coagulant therapy were not excluded. The TUVis procedure was performed according to a classic transurethral resection of the prostate (TURP) scheme following the manufacturer's recommendations. We evaluated subjective functional outcome using self-questionnaires (International Prostate Symptom Score [IPSS] and five-item International Index of Erectile Function [IIEF-5]) and objective criteria (prostate volume, prostate-specific antigen [PSA], uroflowmetry, post residual volume) at baseline and at 1- and 3-month follow-ups. All types of complications were systematically recorded.
RESULTS: Despite 52% of patients receiving anticoagulant therapy before surgery, we reported only 3% with haemorrhagic complications, no blood transfusion, a mean catheterization time of 44 h and a mean postoperative stay of 2.9 nights. No significant change in irrigation time, catheter time or hospital stay was observed in patients with or without anticoagulant therapy. The IPSS and bother scores significantly decreased after the 3-month follow-up (57% and 59%, respectively), but the average remaining prostate volume was 29 cc and the tissue ablation rate was only 0.5 cc/min. Three major complications occurred, consisting of two urinary fistulas and one partial bladder coagulation.
CONCLUSIONS: The TUVis procedure has a proven fast postoperative recovery time, good short-term functional outcome and good haemostatic efficiency. However, the tissue ablation rate was lower than expected and we encountered three major complications, the mechanisms of which remain unclear. Considering the high energy level required to create the plasma effect, the generator, cable and resectoscope must be carefully checked before each procedure.
Grégoire Robert; Aurélien Descazeaud; Nicolas Barry Delongchamps; Charles Ballereau; Olivier Haillot; Christian Saussine; François Kleinklauss; Gilles Pasticier; Abdel-Rahmène Azzouzi; Bertrand Lukacs; Olivier Dumonceau; Marc Fourmarier; Alexandre De La Taille; Marian Devonec
Related Documents :
12534908 - Feasibility and usefulness of laparoscopic radical prostatectomy: kobe university exper...
11896478 - Combined oral therapy with sildenafil and doxazosin for the treatment of non-organic er...
11377328 - Efficacy, safety, and use of sildenafil in urologic practice.
16998858 - Preoperative erectile function is one predictor for post prostatectomy incontinence.
15692238 - Management of patients with acute venous thromboembolism: findings from the riete regis...
21063678 - No impact of severe varus deformity on clinical outcome after posterior stabilized tota...
Publication Detail:
Type:  Journal Article     Date:  2010-11-02
Journal Detail:
Title:  BJU international     Volume:  110     ISSN:  1464-410X     ISO Abbreviation:  BJU Int.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-07-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100886721     Medline TA:  BJU Int     Country:  England    
Other Details:
Languages:  eng     Pagination:  555-60     Citation Subset:  IM    
Copyright Information:
CHU de Bordeaux Pellegrin, Bordeaux-2 Victor Segalen University, Bordeaux, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Therapeutic value of lymph node dissection at radical prostatectomy: a population-based case-cohort ...
Next Document:  Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functi...